These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

873 related items for PubMed ID: 17331327

  • 1. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y.
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [Abstract] [Full Text] [Related]

  • 2. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
    Hildebrand RB, Lammers B, Meurs I, Korporaal SJ, De Haan W, Zhao Y, Kruijt JK, Praticò D, Schimmel AW, Holleboom AG, Hoekstra M, Kuivenhoven JA, Van Berkel TJ, Rensen PC, Van Eck M.
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
    [Abstract] [Full Text] [Related]

  • 3. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 4. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
    Zhao Z, de Beer MC, Cai L, Asmis R, de Beer FC, de Villiers WJ, van der Westhuyzen DR.
    Arterioscler Thromb Vasc Biol; 2005 Jan 25; 25(1):168-73. PubMed ID: 15514202
    [Abstract] [Full Text] [Related]

  • 5. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y, Watanabe T, Suguro T, Nagashima M, Kato R, Hongo S, Itabe H, Miyazaki A, Hirano T, Adachi M.
    J Hypertens; 2008 Oct 25; 26(10):1955-65. PubMed ID: 18806619
    [Abstract] [Full Text] [Related]

  • 6. Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice.
    Xiao HB, Yang ZC, Jia SJ, Li NS, Jiang DJ, Zhang XH, Guo R, Zhou Z, Deng HW, Li YJ.
    Life Sci; 2007 Jun 13; 81(1):1-7. PubMed ID: 17532008
    [Abstract] [Full Text] [Related]

  • 7. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice.
    Zhang S, Picard MH, Vasile E, Zhu Y, Raffai RL, Weisgraber KH, Krieger M.
    Circulation; 2005 Jun 28; 111(25):3457-64. PubMed ID: 15967843
    [Abstract] [Full Text] [Related]

  • 8. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb 28; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 9. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
    Yoshikawa T, Shimano H, Chen Z, Ishibashi S, Yamada N.
    Horm Metab Res; 2001 Aug 28; 33(8):472-9. PubMed ID: 11544561
    [Abstract] [Full Text] [Related]

  • 10. Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice.
    Macdonald DL, Terry TL, Agellon LB, Nation PN, Francis GA.
    Arterioscler Thromb Vasc Biol; 2003 Sep 01; 23(9):1583-8. PubMed ID: 12855483
    [Abstract] [Full Text] [Related]

  • 11. Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient mice.
    Carnicer R, Navarro MA, Arbonés-Mainar JM, Acín S, Guzmán MA, Surra JC, Arnal C, de Las Heras M, Blanco-Vaca F, Osada J.
    Life Sci; 2007 Jan 23; 80(7):638-43. PubMed ID: 17118406
    [Abstract] [Full Text] [Related]

  • 12. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF.
    Circulation; 2003 Nov 04; 108(18):2258-63. PubMed ID: 14581413
    [Abstract] [Full Text] [Related]

  • 13. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K, Lopez R, Kirk EA, Chait A, Wight TN, deBeer FC, LeBoeuf RC.
    Arterioscler Thromb Vasc Biol; 2005 Apr 04; 25(4):785-90. PubMed ID: 15692094
    [Abstract] [Full Text] [Related]

  • 14. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T, Li Y, Shih DM, Wang X, Laubach VE, Matsumoto AH, Helm GA, Lusis AJ, Shi W.
    Life Sci; 2006 Jul 04; 79(6):525-31. PubMed ID: 16516241
    [Abstract] [Full Text] [Related]

  • 15. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M, van der Hoogt CC, de Haan W, Offerman EH, Dallinga-Thie GM, Jukema JW, Havekes LM, Rensen PC.
    Arterioscler Thromb Vasc Biol; 2006 Nov 04; 26(11):2552-9. PubMed ID: 16946130
    [Abstract] [Full Text] [Related]

  • 16. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C, Chen YC, Hausding C, Ahrens I, Kyaw TS, Tay C, Allen T, Jandeleit-Dahm K, Sweet MJ, Akira S, Bobik A, Peter K, Agrotis A.
    Arterioscler Thromb Vasc Biol; 2014 Mar 04; 34(3):516-25. PubMed ID: 24436372
    [Abstract] [Full Text] [Related]

  • 17. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
    Harder C, Lau P, Meng A, Whitman SC, McPherson R.
    Arterioscler Thromb Vasc Biol; 2007 Apr 04; 27(4):858-64. PubMed ID: 17272756
    [Abstract] [Full Text] [Related]

  • 18. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B, Freund M, Ravanat C, Magnenat S, Cazenave JP, Gachet C.
    Circulation; 2008 Aug 12; 118(7):754-63. PubMed ID: 18663083
    [Abstract] [Full Text] [Related]

  • 19. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.
    Circulation; 2005 Sep 13; 112(11):1636-43. PubMed ID: 16145000
    [Abstract] [Full Text] [Related]

  • 20. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
    Hong SC, Zhao SP, Wu ZH.
    Int J Cardiol; 2007 Jan 31; 115(1):29-35. PubMed ID: 16766063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.